M&G PLC

Position in BMY — Bristol Myers Squibb Co

CIK 1802539 London, X0

Position in BMY

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$349,595,091

-$35,292,754 QoQ

Shares Held

5,764,140

-19.2% QoQ

Ownership

0.282%

of shares outstanding

% of Portfolio

1.88%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 98.80296106617813.ToString("F0")% Shared 0.ToString("F0")% None 1.1970389338218712.ToString("F0")%

Healthcare · as of Mar 31, 2026

M&G PLC holds $1,488,143,891 across 11 Drug Manufacturers - General names. BMY ranks #2 (23.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	4,204,199	$829,152,126
2	BMY	Bristol Myers Squibb Co This page	5,764,140	$349,595,091
3	AMGN	Amgen Inc	439,063	$154,484,316
4	ABBV	AbbVie Inc.	262,231	$57,032,620
5	MRK	Merck & Co., Inc.	298,044	$35,851,712
6	JNJ	Johnson & Johnson	76,011	$18,580,128
7	PFE	Pfizer Inc	546,673	$15,350,577
8	GILD	Gilead Sciences, Inc.	95,757	$13,345,653

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$349,595,091	5,764,140	-19.2%	Shares	Defined	2026-05-13
2025-12-31	$384,887,845	7,135,481	+3.6%	Shares	Defined	2026-02-12
2025-09-30	$310,521,978	6,885,188	+1.4%	Shares	Defined	2025-11-07
2025-06-30	$314,222,306	6,788,125	-1.0%	Shares	Sole	2025-08-08
2025-03-31	$418,155,917	6,856,139	-12.9%	Shares	Sole	2025-05-13
2024-12-31	$445,437,884	7,875,493	-14.2%	Shares	Sole	2025-02-11
2024-09-30	$475,176,434	9,183,928	-5.8%	Shares	Sole	2024-10-31
2024-06-30	$404,960,151	9,751,027	+34.1%	Shares	Sole	2024-07-16
2024-03-31	$394,279,865	7,270,512	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.